Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9873732rdf:typepubmed:Citationlld:pubmed
pubmed-article:9873732lifeskim:mentionsumls-concept:C0678133lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C0033262lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C0002475lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C0007428lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C0012512lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C0013089lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C0144576lld:lifeskim
pubmed-article:9873732lifeskim:mentionsumls-concept:C1548818lld:lifeskim
pubmed-article:9873732pubmed:issue23lld:pubmed
pubmed-article:9873732pubmed:dateCreated1999-1-21lld:pubmed
pubmed-article:9873732pubmed:abstractTextSubstrates containing doxorubicin (DOX), paclitaxel (taxol), and mitomycin C (MMC) attached to the cathepsin B-sensitive dipeptide Phe-Lys via a self-immolative spacer were prepared as model compounds for internalizing anticancer immunoconjugates. Cathepsin B-mediated release rates of free drug, rat liver lysosomal susceptibility and human plasma stability were measured for each.lld:pubmed
pubmed-article:9873732pubmed:languageenglld:pubmed
pubmed-article:9873732pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873732pubmed:citationSubsetIMlld:pubmed
pubmed-article:9873732pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873732pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873732pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873732pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873732pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873732pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873732pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9873732pubmed:statusMEDLINElld:pubmed
pubmed-article:9873732pubmed:monthDeclld:pubmed
pubmed-article:9873732pubmed:issn0960-894Xlld:pubmed
pubmed-article:9873732pubmed:authorpubmed-author:FirestoneR...lld:pubmed
pubmed-article:9873732pubmed:authorpubmed-author:KnipeJ OJOlld:pubmed
pubmed-article:9873732pubmed:authorpubmed-author:DubowchikG...lld:pubmed
pubmed-article:9873732pubmed:authorpubmed-author:MosureKKlld:pubmed
pubmed-article:9873732pubmed:issnTypePrintlld:pubmed
pubmed-article:9873732pubmed:day1lld:pubmed
pubmed-article:9873732pubmed:volume8lld:pubmed
pubmed-article:9873732pubmed:ownerNLMlld:pubmed
pubmed-article:9873732pubmed:authorsCompleteYlld:pubmed
pubmed-article:9873732pubmed:pagination3347-52lld:pubmed
pubmed-article:9873732pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:meshHeadingpubmed-meshheading:9873732-...lld:pubmed
pubmed-article:9873732pubmed:year1998lld:pubmed
pubmed-article:9873732pubmed:articleTitleCathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol), mitomycin C and doxorubicin.lld:pubmed
pubmed-article:9873732pubmed:affiliationBristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492-7660, USA.lld:pubmed
pubmed-article:9873732pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:9873732lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9873732lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9873732lld:pubmed